Purpose: To report a patient with thymoma-associated retinopathy presenting as having a good visual prognosis.

Methods: Case report and literature review.

Case Report: A 42-year-old female patient was referred to our hospital for complaints of sudden visual-field defects bilaterally. Decimal corrected visual acuity (VA) was 1.5 and 1.2 in the right (RE) and left eyes (LE), respectively. Fundus autofluorescence revealed hyper-autofluorescence from the posterior pole to mid-peripheral retina in both eyes. Full-field electroretinography (ERG) amplitudes were reduced to 20-50% and 30-50% of our controls for the scotopic and photopic conditions, respectively. A systemic examination revealed the presence of thymoma, and the patient underwent thymectomy and immunosuppression therapies. Immunohistochemical analysis using the patient's serum showed immunolabeling on the photoreceptor inner segment and outer plexiform layer in the monkey retina. Two years later, VA remained at 1.5 and 1.2 in RE and LE. ERG amplitudes improved to 30-60% of the controls for the scotopic conditions. However, photopic ERG showed no remarkable change.

Conclusions: To our knowledge, improvement of reduced rod-mediated ERG responses has not been described in seven previously reported patients with thymoma-associated retinopathy. The good visual prognosis of our patient may be associated with well-timed intervention.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10633-020-09764-1DOI Listing

Publication Analysis

Top Keywords

thymoma-associated retinopathy
12
improvement reduced
8
case report
8
report literature
8
good visual
8
erg amplitudes
8
controls scotopic
8
reduced electroretinographic
4
electroretinographic responses
4
responses thymoma-associated
4

Similar Publications

Autoimmune retinopathy (AIR) is a rare, potentially blinding retinal disease that remains a challenging condition to manage when resistant to conventional immune-modulatory approaches. We report clinical and electrophysiological improvement in a 49-year-old patient who underwent an autologous hematopoietic stem cell transplant (aHSCT) for thymoma-associated AIR after experiencing progressive disease despite receiving periocular and systemic steroids, mycophenolate mofetil, baricitinib, tacrolimus, bortezomib, rituximab, plasmapheresis, and intravenous immunoglobulin. The aHSCT had two stages: (i) peripheral blood stem cell harvest following mobilization with cyclophosphamide and granulocyte colony-stimulating factor, and (ii) conditioning regimen with plasmapheresis, rituximab, cyclophosphamide, and anti-thymocyte globulin high-dose therapy, followed by autologous hematopoietic cell infusion of 5.

View Article and Find Full Text PDF

Purpose: To report a patient with thymoma-associated retinopathy presenting as having a good visual prognosis.

Methods: Case report and literature review.

Case Report: A 42-year-old female patient was referred to our hospital for complaints of sudden visual-field defects bilaterally.

View Article and Find Full Text PDF

We report a case of anti-40kDa protein autoimmune retinopathy developing 9 years after thymoma excision on a background of Good Syndrome-associated cytomegalovirus (CMV) retinitis that suggests a separate pathogenetic pathway from that of previously reported thymoma-associated autoimmune retinopathies.

View Article and Find Full Text PDF

Cytomegalovirus (CMV) retinitis is a re-activation infection associated with severely impaired T cell-mediated immunity. We describe a patient with long-standing Crohn's disease and thymoma who developed severe CMV retinitis. While thymoma can be associated with impaired humoral immunity and a quantitative CD4+ T helper cell deficiency, these were not evident in our patient.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!